Kathrin A. Schmohl
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
TGF-β1-based restoration of sodium iodide symporter expression in radioiodine-refractory differentiated thyroid cancer via engineered MSCs.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 21, 2025
Mesenchymal Stem Cell-mediated Image-guided Sodium Iodide Symporter (NIS) Gene Therapy Improves Survival of Glioblastoma-bearing Mice.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 04, 2022
The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy.
Journal: EJNMMI research
Published: October 07, 2021
Selective sodium iodide symporter (NIS) genetherapy of glioblastoma mediatedby EGFR-targeted lipopolyplexes.
Journal: Molecular therapy oncolytics
Published: May 29, 2021
An unusual case of struma ovarii.
Journal: Endocrinology, diabetes & metabolism case reports
Published: December 31, 2020
Integrin αvβ3-dependent thyroid hormone effects on tumour proliferation and vascularisation.
Journal: Endocrine-related cancer
Published: August 28, 2020
Regional Hyperthermia Enhances Mesenchymal Stem Cell Recruitment to Tumor Stroma: Implications for Mesenchymal Stem Cell-Based Tumor Therapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 05, 2020
Integrin αvβ3-Mediated Effects of Thyroid Hormones on Mesenchymal Stem Cells in Tumor Angiogenesis.
Journal: Thyroid : official journal of the American Thyroid Association
Published: December 10, 2019
Thyroid Hormone Effects on Mesenchymal Stem Cell Biology in the Tumour Microenvironment.
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Published: October 25, 2019
Tetrac as an anti-angiogenic agent in cancer.
Journal: Endocrine-related cancer
Published: April 01, 2019
Last Updated: 09/26/2026